Medicine & TechnologyBioengineers reimagine the CRISPR system as a Swiss Army knife by repurposing it to make a mini version for easier cell engineering and gene therapy to treat rheumatoid arthritis and other diverse ailments.
A new study analyzed the correlation between the protein cell p53 gain-of-function and the effects of aneuploidy. It aims to design a drug that can restore the natural function of p53 to suppress cancer.
The World Health Organization (WHO) announced its new guidelines for human genome editing that took two years to complete. Despite that, the health agency still believes genetically modified babies are a bad idea.
It seems that the CRISPR technology is worth a court battle after the patent battle between the Broad Institute and the University of California. Now, several scientists are seeing light to this gene technology which can actually solve epidemics like malaria.
If the battle of the sexes was fought by mosquitoes, it would already be over. Researchers from Virginia Tech's Fralin Life Science Institute has discovered that male mosquitoes aren't relevant at all, at least in the realm of transmissible diseases.
Three major universities are now engaged in a patent lawsuit to protect their rights to use genome editing technology called CRISPR-Cas9. The fallout will have far more impact than the simple settling of ownership and intellectual property rights, however; experts believe that CRISPR-Cas9 may be the most efficient route toward a ticking off items on a laundry list of amazing biotechnological discoveries.
College rivalries are nothing new. Some even reach legendary proportions. USC vs. Notre Dame, Alabama vs. Auburn, Army vs. Navy. They make for great football. Not so much when it comes to technological rights, as we're discovering in the ongoing battle between UC Berkeley and MIT, as they wrestle over the patent for a machine that just might revolutionize genetic engineering.